If the Obama administration allows large scale drug reimportation from Europe, EU nations will effectively set many drug prices in US. Rather than make the right but politically weak economic argument in response, industry is relying on a more shaky argument to deter reimportation — that imports from overseas are dangerous for the public’s health.